Can Heart Drug Prevent Cardiotoxicity in Breast Cancer Care? Sacubitril-valsartan does not significantly attenuate the adjuvant breast cancer therapy-related ejection fraction decline but appears to prevent chronic myocardial injury and stress, a study shows.

Novartis' Entresto can help with heart problems caused by the chemotherapy drugs epirubicin and cyclophosphamide.

#cancer #oncology #breastcancer #neoadjuvant #sacubitril #valsartan

www.medscape.com/viewarticle/...

MSN Pharmaceuticals Achieves Milestone with U.S. Launch of Generics for Heart Failure Treatment MSN Pharmaceuticals celebrates the U.S. launch of Sacubitril and Valsartan Tablets after overcoming legal battles. This launch aids in chronic heart failure management.

MSN Pharmaceuticals Achieves Milestone with U.S. Launch of Generics for Heart Failure Treatment #United_States #Piscataway #MSN_Pharmaceuticals #Sacubitril #Valsartan

Do you take or have you taken: Entresto? Generic: Sacubitril; Valsartan. Therapy Class: Cardiovascular agents – misc. Consider sharing your story with the Oregon Prescription Drug Affordability Board on July 16.

The OR PDAB is reviewing high-cost drugs that may strain OR patients or our healthcare system. PDAB’s 1st Review Will Be Of: Vraylar (Cariprazine HCl) Entresto (Sacubitril; Valsartan) Ajovy (Fremanezumab-vfrm) Emgality (Galcanezumab-gnlm) Nurtec (Rimegepant/ rimegepant sulfate) Ubrelvy (Ubrogepant)

Your Voice Matters! If you have taken any of these medications consider sharing your story at the July 16 PDAB meeting How to Share Your Experience Submit a comment - by July 14 at 9AM Speak at the meeting - sign up by July 15 at 9AM

The Oregon Prescription Drug Affordability Board is reviewing #Entresto (Generic: #Sacubitril , #Valsartan) on July 16 starting at 9 AM.

If you or someone you know has taken this medication, consider sharing your experience. Public comment: dfr.oregon.gov/pdab/Pages/p...

#OCAP #HealthPolicy